Search images on Google Product Monograph
Active Ingredients:
- bortezomib (bortezomib mannitol boronic ester), 2.5 MG/VIAL
DIN: 02467003
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01XG - (ATC, WHO)
- L01XG01 - BORTEZOMIB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 10ML VIAL